TITLE

The HPV vaccine: An analysis of the FUTURE II study

AUTHOR(S)
Howard, Michelle; Lytwyn, Alice
PUB. DATE
December 2007
SOURCE
Canadian Family Physician;Dec2007, Vol. 53 Issue 12, p2157
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article analyzes the efficacy of Gardasil, a vaccine, in treating human papillomavirus (HPV) diseases. It is a randomized double-blind placebo-controlled trial which evaluate the effectiveness of the vaccine for HPV types 6, 11, 16, and 18. The research cites that Gardasil vaccine is effective in preventing the HPV types in girls and women ages 9-26 years old. It also discovers the potential use of Gardasil vaccine for cervical cancer treatment.
ACCESSION #
28351047

 

Related Articles

  • RESEARCH.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;10/1/2011, Vol. 343 Issue 7825, p676 

    The article reports on research related to quadrivalent human papillomavirus vaccination, blood donation by men having sex with men and cardiometabolic disorders. It states that quadrivalent vaccines for the prevention of cervical cancer are cost effective. It also informs about the study...

  • When the Patient Asks. Stabb, Jessica E.; Buckley, Rebecca // JAAPA: Journal of the American Academy of Physician Assistants (;Jan2011, Vol. 24 Issue 1, p53 

    The article provides an answer to the question related to the benefits of human papillomavirus vaccine.

  • Patient Information.  // JAAPA: Journal of the American Academy of Physician Assistants (;Jan2011, Vol. 24 Issue 1, p54 

    The article provides an answer to the question related to human papillomavirus.

  • Recurrent laryngeal papillomatosis: successful treatment with human papillomavirus vaccination. Peter Mudry // Archives of Disease in Childhood;May2011, Vol. 96 Issue 5, p476 

    The authors describe the case of a 5-year-old girl with recurrent laryngeal papillomatosis (RLP) due to human papillomavirus (HPV) type 11, who required frequent surgical treatment. Complete recovery occurred after HPV vaccination (Gardasil). Confirmed remission of RLP has continued during the...

  • Human Papillomavirus DNA Detection in Older Women-Implications for Cancer Screening and Prevention. Ermel, Aaron C.; Fife, Kenneth H. // Journal of Infectious Diseases;9/1/2016, Vol. 214 Issue 5, p657 

    An introduction is presented in which the editor discusses various reports within the issue on topics including human papillomavirus, DNA detection in cancer patient and cancer treatment.

  • Association of Posttherapy Positron Emission Tomography With Tumor Response and Survival in Cervical Carcinoma. Schwarz, Julie K.; Siegel, Barry A.; Dehdashti, Farrokh; Grigsby, Perry W. // JAMA: Journal of the American Medical Association;11/21/2007, Vol. 298 Issue 19, p2289 

    This article reports on the findings of a study that examine the association of posttherapy positron emission tomography to tumor response and survival rates in women with cervical cancer. The development of the human papilloma virus (HPV) vaccine to prevent some cases of cervical cancer does...

  • A Qualitative Analysis of Factors Influencing HPV Vaccine Uptake in Soweto, South Africa among Adolescents and Their Caregivers. Katz, Ingrid T.; Nkala, Busisiwe; Dietrich, Janan; Wallace, Melissa; Bekker, Linda-Gail; Pollenz, Kathryn; Bogart, Laura M.; Wright, Alexi A.; Tsai, Alexander C.; Bangsberg, David R.; Gray, Glenda E. // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Background: In South Africa, the prevalence of oncogenic Human Papillomavirus (HPV) may be as high as 64%, and cervical cancer is the leading cause of cancer-related death among women. The development of efficacious prophylactic vaccines has provided an opportunity for primary prevention. Given...

  • HPV and Cervical Cancer. Leaver, Dennis; Labonte, Geri // Radiation Therapist;Spring2010, Vol. 19 Issue 1, p27 

    Human papillomaviruses (HPVs) are estimated to cause a half million cases of cervical cancer worldwide each year. This article reviews the connection between HPVs and cervical cancer, discusses the HPV vaccine and provides an overview of cervical cancer symptoms, staging and treatment. Case...

  • Genital Human Papillomavirus Infection among Women in Bangladesh: Findings from a Population-Based Survey. Nahar, Quamrun; Sultana, Farhana; Alam, Anadil; Islam, Jessica Yasmine; Rahman, Mustafizur; Khatun, Fatema; Alam, Nazmul; Dasgupta, Sushil Kanta; Marions, Lena; Ashrafunnessa; Kamal, Mohammed; Cravioto, Alejandro; Reichenbach, Laura // PLoS ONE;Oct2014, Vol. 9 Issue 10, p1 

    Background: There has been no population-based study on human papillomavirus (HPV) prevalence or its genotypes in Bangladesh; a country eligible for GAVI funding for HPV vaccine. Methods: We used baseline survey data of a prospective cohort study that was conducted in one urban and one rural...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics